Journal article
Abstract P6-10-09: Mutational landscape of breast cancer patients in ROME trial: preliminary results
Abstract
Abstract
BACKGROUND: The Rome Trial is a randomized phase II trial (NCT04591431). The aim is to evaluate efficacy and safety of a tailored treatment (TT) compared to standard of care (SoC) in patients with solid tumors. Here we report the preliminary results of the molecular alterations, microsatellite status (MS) and tumor mutational burden (TMB) in metastatic breast cancer (mBC) cohort. METHODS: MBC patients who received at …
Authors
Botticelli A; Scagnoli S; Conte P; Cremolini C; Ascierto PA; Cappuzzo F; Aglietta M; Mazzuca F; Capoluongo E; Blandino G
Journal
Cancer Research, Vol. 83, No. 5_Supplement,
Publisher
American Association for Cancer Research (AACR)
Publication Date
March 1, 2023
DOI
10.1158/1538-7445.sabcs22-p6-10-09
ISSN
0008-5472